On June 30, 2026, FINRA published “Recommendations Based on a Review of the Policies, Procedures, Processes, and Practices of FINRA’s ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results